{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:26:55Z","timestamp":1789712815754,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"HSRD","award":["Automated 2015"],"award-info":[{"award-number":["Automated 2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10620-017-4548-4","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T03:32:15Z","timestamp":1491363135000},"page":"1472-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies"],"prefix":"10.1007","volume":"62","author":[{"given":"John B.","family":"Dever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie H.","family":"Ducom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Herrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Groessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"4548_CR1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep.27978","volume":"62","author":"BR Edlin","year":"2015","unstructured":"Edlin BR, Eckhardt BJ, Shu MA, et al. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015;62:1353\u20131363.","journal-title":"Hepatology"},{"key":"4548_CR2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","volume":"62","author":"KN Ly","year":"2016","unstructured":"Ly KN, Hughes EM, Jiles RB, et al. Rising mortality associated with Hepatitis C Virus in the United States, 2003\u20132013. Clin Infect Dis. 2016;62:1287\u20131288.","journal-title":"Clin Infect Dis"},{"key":"4548_CR3","unstructured":"CDC. Hepatitis C kills more Americans than any other infectious disease: Center for Disease Control and Prevention, 2016 (\n                        https:\/\/www.cdc.gov\/media\/releases\/2016\/p0504-hepc-mortality.html\n                        \n                    )."},{"key":"4548_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/epirev\/mxu002","volume":"37","author":"LA Beste","year":"2015","unstructured":"Beste LA, Ioannou GN. Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs. Epidemiol Rev. 2015;37:131\u2013143.","journal-title":"Epidemiol Rev"},{"key":"4548_CR5","first-page":"120A","volume":"64","author":"AM Moon","year":"2016","unstructured":"Moon AM, Green P, Berry K, et al. Towards eradication of hepatitis C virus infection in the Veterans Affairs national healthcare system: a study of 107,079 antiviral treatment regimens administered from 1999 to 2015. Abs 227. Hepatology. 2016;64:120A.","journal-title":"Hepatology"},{"key":"4548_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamainternmed.2013.12505","volume":"174","author":"J McCombs","year":"2014","unstructured":"McCombs J, Matsuda T, Tonnu-Mihara I, et al. The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry. JAMA Intern Med. 2014;174:204\u2013212.","journal-title":"JAMA Intern Med"},{"key":"4548_CR7","first-page":"533","volume":"20","author":"PS Belperio","year":"2014","unstructured":"Belperio PS, Backus LI, Ross D, et al. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system. J Manag Care Spec Pharm. 2014;20:533\u2013540.","journal-title":"J Manag Care Spec Pharm"},{"key":"4548_CR8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/apt.13696","volume":"44","author":"LI Backus","year":"2016","unstructured":"Backus LI, Belperio PS, Shahoumian TA, et al. Comparative effectiveness of ledipasvir\/sofosbuvir\u00a0\u00b1\u00a0ribavirin vs. ombitasvir\/paritaprevir\/ritonavir\u00a0+\u00a0dasabuvir\u00a0\u00b1\u00a0ribavirin in 6961 genotype 1 patients treated in routine medical practice. Aliment Pharmacol Ther. 2016;44:400\u2013410.","journal-title":"Aliment Pharmacol Ther"},{"key":"4548_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hep.28625","volume":"64","author":"LI Backus","year":"2016","unstructured":"Backus LI, Belperio PS, Shahoumian TA, et al. Real world effectiveness of Ledipasvir\/Sofosbuvir in 4365 treatment-naive genotype 1 Hepatitis C infected patients. Hepatology. 2016;64:405\u2013414.","journal-title":"Hepatology"},{"key":"4548_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.genhosppsych.2012.11.002","volume":"35","author":"CS North","year":"2013","unstructured":"North CS, Hong BA, Adewuyi SA, et al. Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations. Gen Hosp Psychiatry. 2013;35:122\u2013128.","journal-title":"Gen Hosp Psychiatry"},{"key":"4548_CR11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMp1302973","volume":"368","author":"SD Holmberg","year":"2013","unstructured":"Holmberg SD, Spradling PR, Moorman AC, et al. Hepatitis C in the United States. N Engl J Med. 2013;368:1859\u20131861.","journal-title":"N Engl J Med"},{"key":"4548_CR12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2011.05.032","volume":"56","author":"JR Kramer","year":"2012","unstructured":"Kramer JR, Kanwal F, Richardson P, et al. Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012;56:320\u2013325.","journal-title":"J Hepatol"},{"key":"4548_CR13","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1572-0241.2008.01877.x","volume":"103","author":"SB Ho","year":"2008","unstructured":"Ho SB, Groessl E, Dollarhide A, et al. Management of chronic hepatitis C in veterans: the potential of integrated care models. Am J Gastroenterol. 2008;103:1810\u20131823.","journal-title":"Am J Gastroenterol"},{"key":"4548_CR14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u20131325.","journal-title":"Hepatology"},{"key":"4548_CR15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-159-5-201309030-00021","volume":"159","author":"R Chou","year":"2013","unstructured":"Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Ann Intern Med. 2013;159:372.","journal-title":"Ann Intern Med"},{"key":"4548_CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cid\/cit245","volume":"57","author":"SD Holmberg","year":"2013","unstructured":"Holmberg SD, Lu M, Rupp LB, et al. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis. 2013;57:240\u2013246.","journal-title":"Clin Infect Dis"},{"key":"4548_CR17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00535-013-0914-y","volume":"49","author":"N Tamaki","year":"2014","unstructured":"Tamaki N, Kurosaki M, Matsuda S, et al. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J Gastroenterol. 2014;49:1495\u20131503.","journal-title":"J Gastroenterol"},{"key":"4548_CR18","unstructured":"VA. Department of Veterans Affairs Directive Attachment B, Initiation of HCV Treatment: Protocol for Prioritization. May 21, 2015, 2015."},{"key":"4548_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u2013383.","journal-title":"J Chronic Dis"},{"key":"4548_CR20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jvh.12506","volume":"23","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Bacon BR, Dieterich DT, et al. Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network. J Viral Hepat. 2016;23:447\u2013454.","journal-title":"J Viral Hepat"},{"key":"4548_CR21","first-page":"31","volume":"28","author":"OT Sims","year":"2016","unstructured":"Sims OT, Pollio DE, Hong BA, et al. An assessment of concurrent drug and alcohol use among patients seeking treatment for hepatitis C. Ann Clin Psychiatry. 2016;28:31\u201336.","journal-title":"Ann Clin Psychiatry"},{"key":"4548_CR22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-2334-13-234","volume":"13","author":"L Fusfeld","year":"2013","unstructured":"Fusfeld L, Aggarwal J, Dougher C, et al. Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection. BMC Infect Dis. 2013;13:234.","journal-title":"BMC Infect Dis"},{"key":"4548_CR23","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1097\/01.aids.0000192088.72055.90","volume":"19","author":"SH Mehta","year":"2005","unstructured":"Mehta SH, Thomas DL, Sulkowski MS, et al. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV\/HCV-co-infected injection drug users. AIDS. 2005;19:S179\u2013S189.","journal-title":"AIDS"},{"key":"4548_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jsat.2006.10.004","volume":"32","author":"H Hagedorn","year":"2007","unstructured":"Hagedorn H, Dieperink E, Dingmann D, et al. Integrating hepatitis prevention services into a substance use disorder clinic. J Subst Abuse Treat. 2007;32:391\u2013398.","journal-title":"J Subst Abuse Treat"},{"key":"4548_CR25","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.cgh.2015.02.022","volume":"13","author":"SB Ho","year":"2015","unstructured":"Ho SB, Brau N, Cheung R, et al. Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse. Clin Gastroenterol Hepatol. 2015;13:2005\u20132014.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4548_CR26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.27410","volume":"61","author":"JW Galbraith","year":"2015","unstructured":"Galbraith JW, Franco RA, Donnelly JP, et al. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology. 2015;61:776\u2013782.","journal-title":"Hepatology"},{"key":"4548_CR27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.293.10.1223","volume":"293","author":"AX Garg","year":"2005","unstructured":"Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223\u20131238.","journal-title":"JAMA"},{"key":"4548_CR28","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.2105\/AJPH.2014.302164","volume":"104","author":"L Moja","year":"2014","unstructured":"Moja L, Kwag KH, Lytras T, et al. Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am J Public Health. 2014;104:e12\u2013e22.","journal-title":"Am J Public Health"},{"key":"4548_CR29","unstructured":"Center for Medicaid and CHIP Services. Medicaid drug rebate program notice. Assuring medicaid beneficiaries access to hepatitis C drugs. Health and Human Services, Volume Release No. 172. Baltimore, MD, 2015."},{"key":"4548_CR30","doi-asserted-by":"crossref","first-page":"e0135645","DOI":"10.1371\/journal.pone.0135645","volume":"10","author":"A Do","year":"2015","unstructured":"Do A, Mittal Y, Liapakis A, et al. Drug authorization for Sofosbuvir\/Ledipasvir (Harvoni) for chronic HCV infection in a real-world cohort: a new barrier in the HCV Care cascade. PLoS One. 2015;10:e0135645.","journal-title":"PLoS One"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4548-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4548-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4548-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:36:39Z","timestamp":1495524999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4548-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4548"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4548-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]}}}